172 related articles for article (PubMed ID: 37755680)
1. The course of self-perceived cognitive functioning among patients with lymphoma and the co-occurrence with fatigue and psychological distress.
Ekels A; Oerlemans S; Schagen SB; Issa DE; Thielen N; Nijziel MR; van der Poel MWM; Arts LPJ; Posthuma EFM; van de Poll-Franse LV
J Cancer Surviv; 2023 Sep; ():. PubMed ID: 37755680
[TBL] [Abstract][Full Text] [Related]
2. Self-perceived cognitive functioning and quality of life among cancer survivors: results from the PROFILES registry.
Oerlemans S; Schagen SB; van den Hurk CJ; Husson O; Schoormans D; van de Poll-Franse LV
J Cancer Surviv; 2022 Apr; 16(2):303-313. PubMed ID: 33728574
[TBL] [Abstract][Full Text] [Related]
3. Persistent symptoms of fatigue, neuropathy and role-functioning impairment among indolent non-Hodgkin lymphoma survivors: A longitudinal PROFILES registry study.
Ekels A; van de Poll-Franse LV; Posthuma EFM; Kieffer J; Issa DE; Koster A; Nijziel MR; Pruijt JHFM; Stevens WBC; Tick LW; Oerlemans S
Br J Haematol; 2022 Jun; 197(5):590-601. PubMed ID: 35365860
[TBL] [Abstract][Full Text] [Related]
4. Adolescent and young adult (AYA) lymphoma survivors report lower health-related quality of life compared to a normative population: results from the PROFILES registry.
Husson O; Prins JB; Kaal SE; Oerlemans S; Stevens WB; Zebrack B; van der Graaf WT; van de Poll-Franse LV
Acta Oncol; 2017 Feb; 56(2):288-294. PubMed ID: 28077017
[TBL] [Abstract][Full Text] [Related]
5. Impact of therapy and disease-related symptoms on health-related quality of life in patients with follicular lymphoma: results of the population-based PHAROS-registry.
Oerlemans S; Issa DE; van den Broek EC; Nijziel MR; Coebergh JW; Mols F; van de Poll-Franse LV
Eur J Haematol; 2014 Sep; 93(3):229-38. PubMed ID: 24702126
[TBL] [Abstract][Full Text] [Related]
6. Health-related quality of life and persistent symptoms in relation to (R-)CHOP14, (R-)CHOP21, and other therapies among patients with diffuse large B-cell lymphoma: results of the population-based PHAROS-registry.
Oerlemans S; Issa DE; van den Broek EC; Nijziel MR; Coebergh JW; Huijgens PC; Mols F; van de Poll-Franse LV
Ann Hematol; 2014 Oct; 93(10):1705-15. PubMed ID: 24807105
[TBL] [Abstract][Full Text] [Related]
7. More frequent use of health care services among distressed compared with nondistressed survivors of lymphoma and chronic lymphocytic leukemia: Results from the population-based PROFILES registry.
Arts LPJ; Oerlemans S; Tick L; Koster A; Roerdink HTJ; van de Poll-Franse LV
Cancer; 2018 Jul; 124(14):3016-3024. PubMed ID: 29698556
[TBL] [Abstract][Full Text] [Related]
8. Quality of life more impaired in younger than in older diffuse large B cell lymphoma survivors compared to a normative population: a study from the population-based PROFILES registry.
van der Poel MW; Oerlemans S; Schouten HC; Mols F; Pruijt JF; Maas H; van de Poll-Franse LV
Ann Hematol; 2014 May; 93(5):811-9. PubMed ID: 24318593
[TBL] [Abstract][Full Text] [Related]
9. Lymphoma InterVEntion (LIVE) - patient-reported outcome feedback and a web-based self-management intervention for patients with lymphoma: study protocol for a randomised controlled trial.
Arts LPJ; van de Poll-Franse LV; van den Berg SW; Prins JB; Husson O; Mols F; Brands-Nijenhuis AVM; Tick L; Oerlemans S
Trials; 2017 Apr; 18(1):199. PubMed ID: 28454583
[TBL] [Abstract][Full Text] [Related]
10. Quality of life after successful treatment of early-stage Hodgkin's lymphoma: 10-year follow-up of the EORTC-GELA H8 randomised controlled trial.
Heutte N; Flechtner HH; Mounier N; Mellink WA; Meerwaldt JH; Eghbali H; van't Veer MB; Noordijk EM; Kluin-Nelemans JC; Lampka E; Thomas J; Lugtenburg PJ; Viterbo L; Carde P; Hagenbeek A; van der Maazen RW; Smit WG; Brice P; van Marwijk Kooy M; Baars JW; Poortmans P; Tirelli U; Leeksma OC; Tomsic R; Feugier P; Salles G; Gabarre J; Kersten MJ; Van Den Neste E; Creemers GJ; Gaillard I; Meijnders P; Tertian G; Reman O; Muller HP; Troncy J; Blanc M; Schroyens W; Voogt PJ; Wijermans P; Rieux C; Fermé C; Henry-Amar M;
Lancet Oncol; 2009 Dec; 10(12):1160-70. PubMed ID: 19828373
[TBL] [Abstract][Full Text] [Related]
11. Rituximab: a review of its use in non-Hodgkin's lymphoma and chronic lymphocytic leukaemia.
Plosker GL; Figgitt DP
Drugs; 2003; 63(8):803-43. PubMed ID: 12662126
[TBL] [Abstract][Full Text] [Related]
12. Second malignancy risks after non-Hodgkin's lymphoma and chronic lymphocytic leukemia: differences by lymphoma subtype.
Morton LM; Curtis RE; Linet MS; Bluhm EC; Tucker MA; Caporaso N; Ries LA; Fraumeni JF
J Clin Oncol; 2010 Nov; 28(33):4935-44. PubMed ID: 20940199
[TBL] [Abstract][Full Text] [Related]
13. A high level of fatigue among long-term survivors of non-Hodgkin's lymphoma: results from the longitudinal population-based PROFILES registry in the south of the Netherlands.
Oerlemans S; Mols F; Issa DE; Pruijt JH; Peters WG; Lybeert M; Zijlstra W; Coebergh JW; van de Poll-Franse LV
Haematologica; 2013 Mar; 98(3):479-86. PubMed ID: 22929981
[TBL] [Abstract][Full Text] [Related]
14. Characterization and outcomes of 414 patients with primary SS who developed haematological malignancies.
Hernández-Molina G; Kostov B; Brito-Zerón P; Vissink A; Mandl T; Hinrichs AC; Quartuccio L; Baldini C; Seror R; Szántó A; Isenberg D; Gerli R; Nordmark G; Rasmussen A; Solans-Laque R; Hofauer B; Sène D; Pasoto SG; Rischmueller M; Praprotnik S; Gheita TA; Danda D; Armağan B; Suzuki Y; Valim V; Devauchelle-Pensec V; Retamozo S; Kvarnstrom M; Sebastian A; Atzeni F; Giacomelli R; Carsons SE; Kwok SK; Nakamura H; Fernandes Moça Trevisani V; Flores-Chávez A; Mariette X; Ramos-Casals M;
Rheumatology (Oxford); 2022 Dec; 62(1):243-255. PubMed ID: 35385104
[TBL] [Abstract][Full Text] [Related]
15. Quality of life of patients with chronic lymphocytic leukaemia in the Netherlands: results of a longitudinal multicentre study.
Holtzer-Goor KM; Schaafsma MR; Joosten P; Posthuma EF; Wittebol S; Huijgens PC; Mattijssen EJ; Vreugdenhil G; Visser H; Peters WG; Erjavec Z; Wijermans PW; Daenen SM; van der Hem KG; van Oers MH; Uyl-de Groot CA
Qual Life Res; 2015 Dec; 24(12):2895-906. PubMed ID: 26205768
[TBL] [Abstract][Full Text] [Related]
16. The EORTC Quality of Life Questionnaire for cancer patients (QLQ-C30): Australian general population reference values.
Mercieca-Bebber R; Costa DS; Norman R; Janda M; Smith DP; Grimison P; Gamper EM; King MT
Med J Aust; 2019 Jun; 210(11):499-506. PubMed ID: 31155722
[TBL] [Abstract][Full Text] [Related]
17. Quality of life of survivors 1 year after the diagnosis of diffuse large B-cell lymphoma: a LYSA study.
Paunescu AC; Copie CB; Malak S; Gouill SL; Ribrag V; Bouabdallah K; Sibon D; Rumpold G; Preau M; Mounier N; Haioun C; Jardin F; Besson C
Ann Hematol; 2022 Feb; 101(2):317-332. PubMed ID: 34617134
[TBL] [Abstract][Full Text] [Related]
18. International validation of the EORTC QLQ-CLL17 questionnaire for assessment of health-related quality of life for patients with chronic lymphocytic leukaemia.
Oerlemans S; Efficace F; Kieffer JM; Kyriakou C; Xochelli A; Levedahl K; Petranovic D; Borges FC; Bredart A; Shamieh O; Gziskevicius L; Lehmann J; Scholz CW; Caocci G; Molica S; Stamatopoulos K; Panteliadou AK; Papaioannou M; Alrjoob W; Baliakas P; Rosenquist R; Malak S; Miranda A; Cocks K; van de Poll-Franse L;
Br J Haematol; 2022 May; 197(4):431-441. PubMed ID: 35255152
[TBL] [Abstract][Full Text] [Related]
19. Validity and reliability of the Swedish version of the Memorial Symptom Assessment Scale (MSAS): an instrument for the evaluation of symptom prevalence, characteristics, and distress.
Browall M; Kenne Sarenmalm E; Nasic S; Wengström Y; Gaston-Johansson F
J Pain Symptom Manage; 2013 Jul; 46(1):131-41. PubMed ID: 23195392
[TBL] [Abstract][Full Text] [Related]
20. Composite Small Lymphocytic Lymphoma/Chronic Lymphocytic Leukemia and Follicular Lymphoma: A Clinicopathological Study of Six Cases.
Jelloul FZ; Chen QH; Yang T; Haghi N; Brody J; Zhang X; Sheikh-Fayyaz S
Int J Surg Pathol; 2018 Apr; 26(2):135-144. PubMed ID: 29069998
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
